(FILES) A Syrian health worker prepares a dose of the Vaxzevria AstraZeneca vaccine against the coronavirus, before inoculating a patient in the capital Damascus, on Spetember 9, 2021. British drugmaker AstraZeneca said on May 8, 2024 that it has withdrawn its Covid vaccine Vaxzervria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs. "As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzervria, which is no longer being manufactured or supplied," an AstraZeneca spokeperson said. (Photo by LOUAI BESHARA / AFP) (Photo by LOUAI BESHARA/AFP via Getty Images)